Speak with one of our advisors: 0800 331 7172 or

May, 2018

Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.

Louise will operate across the wide range of Check4Cancer’s clinical services, helping to maintain standards of clinical excellence and patient-focused care. She brings to the team a wealth of experience in senior nursing and clinical management roles, having previously worked for BUPA, HCA International Ltd and Genesis Care. 

Professor Gordon Wishart, founder and Chief Medical Officer of Check4Cancer, said, “Louise’s appointment will strengthen our clinical leadership team, and improve our delivery of high quality early cancer detection services for the private, insured and corporate sectors. Securing a candidate of such high calibre to this senior clinical role illustrates our commitment to deliver clinical excellence as we improve cancer diagnostics in the private sector ”. 

Louise Mills commented, “Check4Cancer is taking significant steps towards meeting the unmet need for private early cancer detection in the UK. Its ambition to improve clinical governance by providing protocol-driven diagnostic protocols for breast and skin cancer that can be audited greatly attracted me to this role, and I look forward to joining such an innovative and ambitious team”.

July, 2016

Great strides have been made in the detection and treatment of cervical cancer since the national Cervical Screening Programme in 1988, with an estimated 100,000 lives having been saved by 2012. Now, our understanding of the connection with a sexually acquired virus is helping to make cervical cancer an almost entirely preventable disease.

Jullien Brady – Clinical Advisor for GynaeCheck (part of Check4Cancer group of companies) – is also a Consultant Obstetrician and Gynaecologist at Bedford Hospital, with extensive experience in the UK cervical screening programme. He explains: “Cervical cancer is effectively a sexually transmitted disease. We now know that almost all cases are caused by exposure to certain strains of human papillomavirus, or HPV.

July, 2016

A “superior” test for cervical cancer is now being offered to millions of women following a successful pilot programme in the UK.

The test, which targets HPV (human papilloma virus), is being rolled out in surgeries and clinics and should be available nationwide within two years.

July, 2016

Mr Jullien Brady, Clinical Advisor for GynaeHealth UK (part of Check4Cancer group of companies)  talks about screening for cervical cancer, why it's important, what it entails, how to get over 'nerves' of having the test and alternative screening options - GynaeCheck

Eliza Flynn shares her story about how she found out she had abnormal cells after a smear test.

June, 2016

13-19 June 2016 is Cervical Cancer Awareness Week, and amongst the many activities organised to help raise awareness, GynaeHealth UK are hosting ‘Ask an expert’ webinar with Mr Jullien Brady, Consultant Gynaecologist on Monday, 20th June at 13.00-13.15. During the 10-15min session, Mr Brady will answer key questions about cervical cancer, cervical screening, HPV tests and treatment options.

June, 2016

To mark Cervical Cancer Awareness Week – a UK-wide initiative led by Jo's Cervical Cancer Trust – Mr Jullien Brady, Clinical Advisor for GynaeHealth UK (part of Check4Cancer group of companies), answers some key questions about cervical cancer, detection and treatment.

February, 2016

2015 proved a turbulent year for national and international politics – but the news that dominated the New Year was cancer, with musicians Lemmy and David Bowie and actor Alan Rickman all dying of the disease within days of each other.

“These deaths occurring so close together were widely regarded as a tragic coincidence,” says Gordon Wishart, Professor of Cancer Surgery and Medical Director of Check4Cancer. “Unfortunately they are indicative of general trends, and we are likely to see this more often. Celebrity cases can help focus attention on efforts to combat the disease, but the important message we need to get across is that cancer affects us all. One in two people born after 1960 will be diagnosed with some form of cancer during their lifetime, so if it is not us, it will be someone we know.”

January, 2016

Recommendations published by the UK National Screening Committee (UK NSC) in January 2016 include switching the NHS Cervical Screening Programme to HPV testing as the primary screening method for cervical cancer.

Currently, the NHS Cervical Screening Programme uses cytology testing to look for abnormal cells that could be the first sign of cancer. Human Papilloma Virus (HPV) testing is used as a secondary measure in women needing further investigation. However, evidence suggests that screening for HPV first will be a more effective way to let women know whether they are at risk of developing cervical cancer.

January, 2016

- New research reveals 40 somethings are ignoring a virus as they wrongly think cervical cancer is a young women’s disease 

- Knowledge gap amongst women in their 40s could be putting their health at risk 

One in five new cervical cancer cases are diagnosed in women in their 60s, but new research[ii] still shun screening of one of the only preventable cancers.

The Human Papilloma Virus (HPV) is the cause of around 99.7% of cervical cancers and increased exposure to high-risk strains of the virus (HR-HPV) in 40-something women means cases in the 60+ age group are on the rise. The virus can take 10 or more years to present as cervical abnormalities.

January, 2016

We are delighted to announce that the GynaeHealth UK (part of Check4Cancer Ltd. group of companies) Customer Service opening times have been extended to offer better service for all clients.

We will now be open from 08.00 to 20.00 (UK time) Monday to Friday and from 09.00 to 12.00 (UK time) on Saturdays.

January, 2016

To mark Cervical Cancer Prevention Week – a UK-wide initiative led by Jo's Cervical Cancer Trust – Mr Jullien Brady, Clinical Advisor for GynaeHealth UK (part of Check4Cancer group of companies), talks about the importance of screening, HPV and the challenge of getting more women to attend their tests.

September, 2015

September is Gynaecological Cancer Awareness Month, and GynaeHealth UK are deligther to share with you the guest blog by women’s cancer charity - The Eve Appeal who lead this in the UK and encourages women to open up and talk more freely about the signs and symptoms of gynaecological cancers.

Here, Chief Executive of The Eve Appeal, Athena Lamnisos talks candidly about the importance of raising awareness of these cancers, busting the myths and lifting the taboos around their signs and symptoms:

It’s clear from our perspective that gynaecological cancers are not talked about enough or a well profiled cause – given the general public’s lack of knowledge around key signs and symptoms, which were highlighted in our campaign last year. One in five women aged 16-25 couldn’t name a single symptom of any of the five gynaecological cancers and the majority of under 35s couldn’t correctly label the vagina on an anatomical diagram.

September, 2015

Earlier this year, we reported on the new cancer task force, set up to combat long waiting times for diagnoses in England – 25% of which were being made too late. Now, further plans have been unveiled, including a target of 95% of people being given a diagnosis or the all-clear within 28 days of being referred by their GP, by 2020.

Figures released in May showed that more than 21,000 people had not been treated within 62 days of their cancer diagnosis in the last financial year, and the NHS had failed to achieve its own targets for treatment. According to these, 85% of cancer patients should be treated within 62 days of being urgently referred by their GP, but just 83.4% were seen on time in 2014-15. While survival rates have been improving, England still lags behind some of the best performing countries. A cross-party committee of MPs recently warned that England’s cancer services had “lost momentum”.

September, 2015

Treatment and detection of cervical cancer has changed radically in the past 25 years, largely as a result of the national screening programme – but there are still signs we need to be wary of, and act upon immediately.

Following the introduction of the national screening programme in 1988, incidence of cervical cancer dropped dramatically. By 2003-2005 it had decreased by 49% (although there has been a small rise of 8% since). Mortality rates have also decreased by 71% between 1971-1973 and 2010-2012, and it is now estimated that cervical screening prevents around 5,000 deaths each year in the UK.

August, 2015

This week, the BBC reports on new research findings that demonstrate how even light consumption of alcohol can increase cancer risk – but the risk primarily affects women.

The US research, published in the British Medical Journal this month, is titled “Light to moderate intake of alcohol, drinking patterns, and risk of cancer” and sets out “to quantify risk of overall cancer across all levels of alcohol consumption among women and men separately, with a focus on light to moderate drinking and never smokers; and assess the influence of drinking patterns on overall cancer risk.”

August, 2015

A new study has revealed that almost a quarter of cancer patients had to make at least three visits to their GP before being sent to hospital for tests that diagnosed their illness.

The research – published in the European Journal of Cancer Care – was undertaken by academics at Cambridge University who studied the experiences of more than 70,000 patients. They found that a total of 23% had been seen by their GP three or more times before being referred to hospital for further scans, blood tests or investigations which diagnosed the illness.

July, 2015

In Cancer: The challenge facing the NHS BBC Health Correspondent Nick Triggle reveals the issues ahead for our struggling health service.

The analysis comes after the recent announcement of a new strategy by NHS England’s cancer taskforce aimed at improving cancer care. Figures released in May showed that more than 21,000 people had not been treated within 62 days of their cancer diagnosis in the last financial year. According to NHS targets, 85% of cancer patients should be treated within 62 days of being urgently referred by their GP, but just 83.4% were seen on time in 2014-15. While survival rates have been improving, England still lags behind some of the best performing countries.

June, 2015

This week is Cervical Screening Awareness Week.

A week where women are reminded that a five-minute appointment at the GP surgery every few years could save your life.

Could we all think of something else we’d rather be doing when our feet are in stirrups and we’re trying to have a breezy conversation while a stranger uses one of Inspector Gadget’s cotton buds to see how our cervix is doing?I’m going to go out on a limb and speak for everyone when I say: Yes, yes we could.

June, 2015

To mark Cervical Screening Awareness Week – a UK-wide initiative led by Jo's Cervical Cancer Trust – Mr Jullien Brady, GYN Check4Cancer, talks about the importance of screening, and how the latest developments can help save more lives.

June, 2015

As Cervical Screening Awareness Week gets underway (15-21 June) the BBC reports how cervical cancer is perceived as a young woman's disease – despite the fact that half of deaths occur in women over 65.

A new survey reveals that, on average, there were 449 deaths as a result of cervical cancer between 2010 and 2012 amongst over-65s, compared to just seven in under-25s. The survey – published in the British Medical Journal – also argues that the age limit for cervical screening should be raised to 70 and that older women should be targeted in health campaigns.

May, 2015

Medical News Today reports that two new studies show an HPV test to be a more accurate means of screening for cervical cancer than the traditional Pap test (also known as the smear test in the UK).

Human papillomavirus (HPV) is responsible for over 70% of cervical cancers, and is potentially a key early indicator of cervical cancer risk. Both new studies published in the journal Gynecologic Oncology found that screening for HPV infection alone provides more accurate results for both HPV infection and cervical cancer screening than the alternatives of a Pap or a co-test for these conditions.

24th March: The BBC reported today that actress Angelina Jolie has had her ovaries and fallopian tubes removed as a preventative measure against ovarian cancer.

Jolie – whose mother, grandmother and aunt all died of cancer – carries the mutated gene BRCA1, which significantly increases the carriers risk of developing cancer, specifically breast and ovarian cancer.

19th February: Cervical cancer rates in under 35s have continued to soar, whilst the number having smear tests has fallen to an all-time low.

February 2015: This week saw a BBC news report on cancer that contained shocking news for the UK. ‘Half of UK people will get cancer’ revealed that one in two people in the UK will be diagnosed with cancer at some point in their lives.

Order your GynaeCheck
If you want fast, accurate screening for cervical cancer
© 2018 GynaeHealth UK, 1 The Mill, Copley Hill Business Park, Cambridge Road, Cambridge CB22 3GN - Registered in England and Wales. Company registration number 08866941
All data send on this website is encrypted (SSL).